The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Clozapine and Agranulocytosis Monitoring

Mandatory absolute neutrophil count monitoring during clozapine therapy to detect and manage drug-induced agranulocytosis.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Psikiyatri department. Book Appointment →

What is Clozapine and Agranulocytosis Monitoring?

Clozapine, an atypical antipsychotic with unique efficacy in treatment-resistant schizophrenia and reduced suicidality, carries a 0.4–1% lifetime risk of severe neutropenia (ANC < 500/mm3) or agranulocytosis. Most cases occur within the first 6 months of therapy with peak incidence at 3 months. Mortality of untreated agranulocytosis exceeds 30% but with strict monitoring is now under 0.01%.

The mechanism is thought to involve formation of clozapine reactive metabolites in neutrophil precursors causing apoptosis, with HLA-B*39:01, HLA-DQB1*05:02, and DRB1*03:01 alleles increasing susceptibility. Risk factors include genetic predisposition, certain ethnicities (African ancestry has lower baseline ANC — Benign Ethnic Neutropenia — requiring adjusted thresholds), concomitant myelosuppressive drugs, age over 65, and hematologic disorders.

Monitoring protocols vary by jurisdiction but typically require weekly ANC for the first 6 months, then biweekly for months 6–12, then monthly thereafter for the duration of therapy. Strict thresholds for clozapine continuation, suspension, and rechallenge are defined. Adjunctive treatment with G-CSF (filgrastim) accelerates neutrophil recovery in established agranulocytosis. The FDA REMS program in the US, NPMS in Australia, and analogous registries in other countries support standardized monitoring.

Symptoms

Often asymptomatic, detected on routine blood test
Fever, sore throat
Mucosal ulceration (oral, perianal)
Bacterial infection (pneumonia, sepsis)
Fatigue, malaise
Pallor
Tachycardia from infection
Necrotizing skin or soft tissue infection
Recurrent or atypical infections
Sepsis, septic shock
Lymphadenopathy in infection
Other adverse effects of clozapine (myocarditis, seizure, ileus)
Hypersalivation, sedation (clozapine effects)
Weight gain, metabolic syndrome
Constipation (potentially severe — clozapine ileus)

Risk Factors

First 6 months of clozapine therapy
Age over 65
Concomitant carbamazepine, antineoplastic drugs
HLA-B*39:01, HLA-DQB1*05:02, DRB1*03:01 alleles
Female sex (slight)
Asian, African ancestry (different baseline; benign ethnic neutropenia)
Pre-existing low ANC
Hematologic malignancy
Aplastic anemia history
Chronic infections
Concomitant chemotherapy or radiation
Other myelosuppressive medications
Rapid clozapine titration
Prior episode of clozapine-induced neutropenia
Medication errors leading to dose accumulation

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Fever or signs of infection on clozapine
  • Sore throat, oral ulcers
  • Persistent infection not improving with antibiotics
  • Routine ANC below threshold
  • Missed monitoring blood draws
  • Severe constipation, abdominal distension on clozapine
  • Chest pain, dyspnea suggesting myocarditis
  • New seizure on clozapine
  • Sialorrhea or sedation impacting safety
  • Suspected clozapine toxicity

Treatment Methods

01
Baseline ANC and CBC before starting clozapine
02
Weekly ANC for first 6 months, biweekly months 6-12, monthly thereafter
03
Hold clozapine if ANC < 1500/mm3 (or < 1000 if benign ethnic neutropenia documented) per jurisdiction
04
Stop clozapine and obtain hematology consult if ANC < 1000 (general) or < 500 (BEN)
05
Daily ANC monitoring during clozapine hold
06
Consider G-CSF (filgrastim) for severe neutropenia or fever
07
Investigate alternative causes (other drugs, infection, hematologic disorder)
08
Rechallenge after recovery only after risk-benefit discussion and hematology approval
09
Use REMS or national registry to access medication
10
Monitor for clozapine myocarditis (troponin, CRP, ECG, echo) in first 4 weeks
11
Cardiac surveillance during therapy
12
Anti-cholinergic management of sialorrhea (atropine drops, glycopyrrolate)
13
Aggressive constipation prophylaxis (laxatives, hydration, dietary fiber)
14
Therapeutic drug monitoring of clozapine and norclozapine levels
15
Smoking cessation increases clozapine levels — adjust dose
16
Caffeine, fluvoxamine, ciprofloxacin increase clozapine levels
17
Phenytoin, rifampin, smoking decrease levels
18
Patient and family education on warning signs of agranulocytosis and infection
19
Multidisciplinary care with psychiatry, hematology, primary care
20
Long-term metabolic monitoring (weight, BP, lipids, glucose)

Which Department to Visit?

You can visit our Psikiyatri department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Psikiyatri Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Generalized Anxiety Disorder (GAD)

Psikiyatri

Generalized anxiety disorder is characterized by excessive, difficult-to-control worry most days for at least six months, accompanied by physical symptoms such as muscle tension, fatigue, and sleep disturbance that impair daily functioning.

Psychiatric Insomnia and Sleep Disorders

Psikiyatri

Effects of depression, anxiety and other psychiatric disorders on sleep and their treatment.

Depression

Psikiyatri

What is depression, how does it differ from sadness, and how is it treated?

Anxiety Disorder

Psikiyatri

What is anxiety disorder, how does it differ from normal worry, and how is it overcome?

Panic Attack

Psikiyatri

What is a panic attack, how is this condition — often confused with a heart attack — managed and prevented?

OCD (Obsessive Compulsive Disorder)

Psikiyatri

What is OCD, how are intrusive thoughts and compulsive behaviors treated?

PTSD (Post-Traumatic Stress Disorder)

Psikiyatri

What is PTSD, how are flashbacks and hyperarousal after trauma treated?

Bipolar Disorder

Psikiyatri

Bipolar disorder is a chronic mood disorder characterized by episodes of mania or hypomania alternating with depressive episodes; accurate diagnosis and long-term treatment with mood stabilizers are essential to reduce relapses and improve functioning.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.